Climaco John M 4
4 · CNS Pharmaceuticals, Inc. · Filed Apr 10, 2024
Insider Transaction Report
Form 4
Climaco John M
DirectorChief Executive Officer
Transactions
- Award
Option to purchase common stock
2024-04-08+83,000→ 476,533 totalExercise: $0.26Exp: 2034-04-08→ Common Stock (83,000 underlying) - Award
Restricted Stock Units
2024-04-08+83,000→ 559,533 total→ Common Stock (83,000 underlying)
Footnotes (4)
- [F1]The options set forth in the table vest in 36 equal monthly installments over three years.
- [F2]Issued in connection with the reporting person's employment with the Company.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Company common stock.
- [F4]The restricted stock units set forth in the table vest in eight equal quarterly installments over two years.